Understand · Discuss · Plan together

Warning Signs of Inherited Cancer Risk

These clues are reasons to ask for assessment. They cannot confirm or exclude a hereditary syndrome.

Chapter 3 of 16

3 of 16
Explore all 16 chapters

Patterns worth discussing

  • Cancer unusually young for that cancer type, such as colorectal cancer before 50.
  • Several related cancers on the same side of a family.
  • More than one independent primary cancer in a person, or cancers in both paired organs.
  • Male breast cancer, ovarian cancer, pancreatic cancer or metastatic prostate cancer.
  • Numerous bowel polyps, a rare tumour, or a known pathogenic familial variant.

The details change the meaning

Breast and ovarian cancers together may suggest one group of syndromes; bowel and endometrial cancers may suggest another. A colon polyp is not the same as colon cancer. Two lung cancers in older relatives with tobacco exposure do not, by themselves, establish inherited disease. The clinician checks the complete pattern.

When there is no family history

Testing can still be appropriate for a person’s own diagnosis. Small families, missing records and a newly arising variant are possible explanations for an apparently isolated case. A negative checklist must never override testing recommended by the oncology team.

Family-history conversation checklist

Select what you want to discuss
Select items to prepare your appointment. No risk score is calculated.

Educational only. Selections are processed in this page, are not sent to a server and are not saved by this tool. No names or reports are requested. A checklist cannot rule inherited risk in or out.

Symptoms take a different route

A new breast lump, blood in stool or urine, unusual vaginal bleeding or persistent unexplained symptoms need clinical assessment. Do not wait for genetic results or the next screening appointment. Severe bleeding or sudden serious illness needs urgent care.

Sources and further reading

Accessible sources checked: 19 October 2026. International recommendations are identified where used; care in India requires individual clinical assessment. No claim is made to have directly verified restricted NCCN guidance.